Chapter 15
Methamphetamine and Mental Health
Dr Melinda Campopiano,
Dr Melinda Campopiano
clinical faculty
University of Pittsburgh Medical Center, USA
Search for more papers by this authorDr Melinda Campopiano,
Dr Melinda Campopiano
clinical faculty
University of Pittsburgh Medical Center, USA
Search for more papers by this authorBook Editor(s):Dr Peter Phillips PhD, MSc, RMN, PGCAP, FHEA,
Dr Olive McKeown PhD, MSc, Dip N, CELTT, Cert Obst, RMN, RGN,
Tom Sandford BSc (Hons), Dip N, RGN, RMN,
Dr Peter Phillips PhD, MSc, RMN, PGCAP, FHEA
senior lecturer honorary lecturer member specialist
City University London, UK
Search for more papers by this authorDr Olive McKeown PhD, MSc, Dip N, CELTT, Cert Obst, RMN, RGN
visiting lecturer specialist lecturer practitioner senior lecturer
St George's University, London, UK
Search for more papers by this authorTom Sandford BSc (Hons), Dip N, RGN, RMN
executive director policy adviser regional director general manager Head member
Royal College of Nursing, London, UK
Search for more papers by this authorFirst published: 09 September 2009
Summary
This chapter contains sections titled:
-
Introduction
-
Initiation and continuation of methamphetamine use: missed opportunities
-
Methamphetamine and mental health: intoxication, withdrawal and psychiatric illness
-
Methamphetamine addiction: treatment and outcomes
-
Conclusion
-
Acknowledgements
References
- Academic ED SBIRT Research Collaborative (2007) The impact of screening, brief intervention, and referral for treatment on emergency department patients' alcohol use. Annals of Emergency Medicines 50 (6): 699–710, 710.e1–710.e6.
- Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S (2000) History of the methamphetamine problem. Journal of Psychoactive Drugs 32 (2): 137–141.
- Bailey DN (1987) Amphetamine detection during toxicology screening of a university medical center patient population. Journal of Toxicology–Clinical Toxicology 25 (5): 399–409.
- Barr AM, Panenka WJ, MacEwan GW, et al. (2006) The need for speed: an update on methamphetamine addiction. Journal of Psychiatry and Neuro-science 31 (5): 301–313.
- Brecht ML, Anglin MD, Dylan M (2005) Coerced treatment for methamphetamine abuse: differential patient characteristics and outcomes. American Journal of Drug and Alcohol Abuse 31 (2): 337–356.
- Brecht ML, Greenwell L, von Mayrhauser C, Anglin MD (2006) Two-year outcomes of treatment for methamphetamine use. Journal of Psychoactive Drugs (Suppl. 3): 415–426.
- Buchi KF, Zone S, Langheinrich K, Varner MW (2003) Changing prevalence of prenatal substance abuse in Utah. Obstetrics & Gynecology 102 (1): 27–30.
- Chen CK, Lin SK, Sham PC, et al. (2003) Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine 33 (8): 1407–1414.
- Cho AK, Melega WP (2002) Patterns of methamphetamine abuse and their consequences. Journal of Addictive Diseases 21 (1): 21–34.
- Cohen JB, Dickow A, Horner K, et al. (2003) Abuse and violence history of men and women in treatment for methamphetamine dependence. American Journal on Addictions 12 (5): 377–385.
- Copeland AL, Sorensen JL (2001) Differences between methamphetamine users and cocaine users in treatment. Drug and Alcohol Dependence 62 (1): 91–95.
- Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA (2003) Treatment of methamphetamine abuse: research findings and clinical directions. Journal of Substance Abuse Treatment 24 (3): 267–277.
- Derauf C, LaGasse LL, Smith LM, et al. (2007) Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). American Journal of Drug and Alcohol Abuse 33 (2): 281–289.
- Donovan DM, Wells EA (2007) ‘Tweaking 12-Step’: the potential role of 12-Step self-help group involvement in methamphetamine recovery. Addiction 102 (Suppl. 1): 121–129.
- Ellis RJ, Childers ME, Cherner M, et al. (2003) Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases 188 (12): 1820–1826.
- Gibson DR, Leamon MH, Flynn N (2002) Epidemiology and public health consequences of methamphetamine use in California's Central Valley. Journal of Psychoactive Drugs 34 (3): 313–319.
- Grant KM, Kelley SS, Agrawal S, et al. (2007) Methamphetamine use in rural Midwesterners. American Journal on Addictions 16 (2): 79–84.
- Gurnack AM, Paul W (1997) Factors related to perinatal substance abuse in a California county. Perceptual and Motor Skills 84 (3 Pt 2): 1403–1408.
- Hall JA, Henggeler SW, Felice ME, et al. (1993) Adolescent substance use during pregnancy. Journal of Pediatric Psychology 18 (2): 265–271.
- Herman-Stahl MA, Krebs CP, Kroutil LA, Heller DC (2006) Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents. Journal of Adolescent Health 39 (3): 374–380.
- Herrell JM, Taylor JA, Gallagher C, Dawud-Noursi S (2000) A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment. Journal of Psychoactive Drugs 32 (2): 143–147.
- Kosten TR, O'Connor PG (2003) Management of drug and alcohol withdrawal. New England Journal of Medicine 348 (18): 1786–1795.
- Kresina TF, Normand J, Khalsa J, et al. (2004) Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities. Clinical Infectious Diseases 38 (Suppl. 5): S398–S401.
- London ED, Simon SL, Berman SM, et al. (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry 61 (1): 73–84.
- Luchansky B, Krupski A, Stark K (2007) Treatment response by primary drug of abuse: does methamphetamine make a difference? Journal of Substance Abuse Treatment 32 (1): 89–96.
- McCaughan JA, Carlson RG, Falck RS, Siegal HA (2005) From “Candy Kids” to “Chemi-Kids”: a typology of young adults who attend raves in the Midwestern United States. Substance Use and Misuse 40 (9–10): 1503–1523.
- McGregor C, Srisurapanont M, Jittiwutikarn J, et al. (2005) The nature, time course and severity of methamphetamine withdrawal. Addiction 100 (9): 1320–1329.
- McKetin R, McLaren J, Lubman DI, Hides L (2006) The prevalence of psychotic symptoms among methamphetamine users. Addiction 101 (10): 1473–1478.
- Mecham N, Melini J (2002) Unintentional victims: development of a protocol for the care of children exposed to chemicals at methamphetamine laboratories. Pediatric Emergency Care 18 (4): 327–332.
- Miller WR, Baca C, Compton WM, et al. (2006) Addressing substance abuse in health care settings. Alcoholism: Clinical and Experimental Research 30 (2): 292–302.
- National Institutes of Health (2006) NIDA InfoFacts: Methamphetamine. Bethesda: National Institutes of Health: National Institute on Drug Abuse. www.nida.nih.gov/infofacts/methamphetamine.html.
- Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W (2004) Methamphetamine abstinence syndrome: preliminary findings. American Journal on Addictions 13 (3): 248–255.
- NTP-CERHR (2005) National Toxicology Program NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines. NTP CERHR Monograph 16: vii–III1.
- Perez-Reyes M, White WR, McDonald SA (1991) Clinical effects of daily meth-amphetamine administration. Clinical Neuropharmacology 14 (4): 352–358.
- Rawson RA, Gonzales R, Marinelli-Casey P, Ang A (2007) Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. American Journal on Addictions 16 (4): 291–299.
- Reback CJ, Larkins S, Shoptaw S (2003) Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 15 (6): 775–785.
- Roll JM (2007) Contingency management: an evidence-based component of methamphetamine use disorder treatments. Addiction 102 (Suppl. 1): 114–120.
- Sexton RL, Carlson RG, Leukefeld CG, Booth BM (2006) Methamphetamine use and adverse consequences in the rural southern United States: an ethnographic overview. Journal of Psychoactive Drugs (Suppl. 3): 393–404.
- Siegal HA, Draus PJ, Carlson RG, Falck RS, Wang J (2006) Perspectives on health among adult users of illicit stimulant drugs in rural Ohio. Journal of Rural Health 22 (2): 169–173.
- Simons JS, Oliver MN, Gaher RM, Ebel G, Brummels P (2005) Methamphetamine and alcohol abuse and dependence symptoms: associations with affect lability and impulsivity in a rural treatment population. Addictive Behaviors 30 (7): 1370–1381.
- Sommers I, Baskin D, Baskin-Sommers A (2006) Methamphetamine use among young adults: health and social consequences. Addictive Behaviors 31 (8): 1469–1476.
- Springer AE, Peters RJ, Shegog R, White DL, Kelder SH (2007) Methamphetamine use and sexual risk behaviors in U.S. high school students: findings from a national risk behavior survey. Prevention Science 8(2): 103–113.
- Srisurapanont M, Sombatmai S, Boripuntakul T (2007) Brief intervention for students with methamphetamine use disorders: a randomized controlled trial. American Journal on Addiction 16 (2): 111–116.
- Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neuro-transmitter release by amphetamines: a review. Progress in Neurobiology 75 (6): 406–433.
- Sun AP (2007) Relapse among substance-abusing women: components and processes. Substance Use & Misuse 42 (1): 1–21.
- Thorberg FA, Lyvers M (2006) Negative mood regulation (NMR) expectancies, mood, and affect intensity among clients in substance disorder treatment facilities. Addictive Behaviors 31 (5): 811–820.
- Toumbourou JW, Stockwell T, Neighbors C, et al. (2007) Interventions to reduce harm associated with adolescent substance use. Lancet 369 (9570): 1391–1401.
- US Department of Health and Human Services (2007) Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville: US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies. http://www. oas.samhsa.gov/nsduh/2k6nsduh/2k6Results.pdf.
- US Drug Enforcement Administration (2007) National Drug Threat Assessment 2007: Methamphetamine. US Department of Justice. www.usdoj.gov/dea/concern/18862/meth.htm.
- Vik PW (2007) Methamphetamine use by incarcerated women: comorbid mood and anxiety problems. Women's Health Issues 17 (4): 256–263.
- von MC, Brecht ML, Anglin MD (2002) Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: an emerging profile. Journal of Addictive Diseases 21 (1): 45–60.
- Winslow BT, Voorhees KI, Pehl KA (2007) Methamphetamine abuse. American Family Physician 76 (8): 1169–1174.
- Zule WA, Costenbader EC, Meyer WJ Jr, Wechsberg WM (2007) Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sexually Transmitted Diseases 34 (9): 689–694.
